1st approved Symbicort generic, Breyna, now available in US
WEBAug 7, 2023 · Viatris has launched Breyna, the first U.S.-approved generic version of Symbicort, for patients with chronic obstructive pulmonary disease.
Low-dose Morphine Improves Health in COPD Patients With …
WEBSep 3, 2020 · Regular, low-dose oral morphine led to significant health improvements in adults with advanced chronic obstructive pulmonary disease (COPD) who regularly experienced shortness of breath, according to results of a Phase 4 clinical trial. Treatment with morphine did not cause lung-related side effects, and no additional exacerbation or ...
Trelegy Ellipta Reduces COPD Exacerbations and Improves Lung …
WEBApr 24, 2018 · Recently published results of a Phase 3 trial show that treating COPD patients with Trelegy Ellipta reduced disease exacerbations and improved lung function and quality of life.
COPD Trial Shows Breztri Aerosphere Significantly Reduces...
WEBJun 30, 2020 · A Phase 3 trial shows that Breztri Aerosphere significantly reduces the frequency of COPD exacerbations compared with dual combination therapies.
COPD: Differences Between Chronic Bronchitis and Emphysema
WEBDec 26, 2016 · Patients with chronic bronchitis will have symptoms such as shortness of breath, chronic cough, excessive mucus production and wheezing which can lead to pulmonary hypertension. Patients with emphysema have symptoms such as a barrel chest, enlarged lungs, shortness of breath, and weight loss.
Ensifentrine as COPD maintenance therapy up for FDA approval
WEBJul 3, 2023 · Verona Pharma is asking the FDA to approve ensifentrine, its inhaled therapy, as a maintenance treatment for COPD patients.
Zephyr Valve Boosts Lung Function, Life Quality for COPD Patients:...
WEBMay 27, 2021 · Pulmonx’s Zephyr Valve significantly improved lung function and quality of life in patients with emphysema, new trial data show.
Lupin pens deal for greater US access to Spiriva generic for COPD
WEBSep 11, 2023 · Lupin Pharmaceuticals has penned a deal with low-cost pharmacy Mark Cuban Cost Plus Drugs and the COPD Foundation to broaden access for patients in the U.S. to a generic option of an approved tiotropium bromide dry inhalation powder for chronic obstructive pulmonary disease (COPD).
Revefenacin, Marketed as Yupelri, Approved by FDA to Treat COPD
WEBNov 13, 2018 · Revefenacin, now to be marketed as Yupelri, is the first LAMA to be used once daily by nebulizer approved by the FDA to treat adults with COPD.
First Generic of COPD Inhaler Advair Diskus Approved By FDA
WEBFeb 8, 2019 · The first generic version of Advair Diskus was recently approved by the FDA as a twice-daily breathing maintenance therapy for COPD and asthma patients.